CAPS Medical, developer of a highly selective and minimally invasive non-thermal plasma (NTAP™) device for cancer treatment, announced today the enrollment of the first...
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced that the first patient was treated in a feasibility...
Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of...
Diadem SpA, a company developing AlzoSure Predict, the first blood-based test for the early prediction of progression to Alzheimer's disease (AD), announced that is...
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced the enrollment and dosing of first patient in China...
